VTRS — Viatris Inc. | SharesGrow.com

Viatris Inc. (VTRS) 是一家制药 - 专科与仿制药公司，屬於醫療保健產業, 目前交易價格為 $13.91. 其SharesGrow評分為 38/100, 表明較弱的投資特徵， 7項中通過1項.

SharesGrow calculates the intrinsic value of VTRS = $52.56 (+277.9% 相對於當前價格, 該股票看起來被低估). 分析師共識目標價為 VTRS = $15 (+9.6% 上漲空間).

估值: VTRS 本益比(P/E)為 -4.4 (S&P 500平均約25).

財務數據: 營收為 $14.3B, -4.2%/yr 平均成長. 淨利潤為 $3.5B (虧損), 成長率為 -603.7%/yr. 淨利潤率為 -24.6% (負值). 毛利率為 35.1% (-4.9 pp 趨勢).

資產負債表: 總債務為 $14.7B 對比 $14.7B 股東權益 (D/E比率 1, 適度). 流動比率為 1.3 (充足). 資產負債率為 39.5%. 總資產: $37.2B.

分析師展望: 3 / 12 位分析師評級 VTRS 為買入 (25%) — 意見分歧.

SharesGrow 7項標準細分: Value 60/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 33/100 (Fail), Moat 61/100 (Partial), Future 40/100 (Partial), Income 10/100 (Fail).

$15.25

▲ 9.63% 上漲空間

Average Price Target

基於 12 位華爾街分析師對 Viatris Inc. 提供的12個月價格目標，平均目標價為 $15.25，最高預測為 $18.00，最低預測為 $12.00。

Highest Price Target

$18.00

Average Price Target

$15.25

Lowest Price Target

$12.00

VTRS SharesGrow 評分概覽

38/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

價值 60/100

估值 — P/E, PEG, Forward PEG

成長 15/100

財務數據 — 平均成長

過去 50/100

強勁 — 趨勢

健康 33/100

資產負債表 — D/E比率, 流動比率為

護城河 61/100

毛利率為 + market cap

未來 40/100

分析師展望 — 為買入

收入 10/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — VTRS

✓

價值 Pass

60/100

VTRS 本益比(P/E)為 -4.4 (S&P 500平均約25). Forward PEG -0.49 — Peter Lynch 被低估 (≤1.0). 分析師共識目標價為 $15, 意味著 +7.8% 相對於當前價格 $14. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

VTRS: -4.2%/yr 營收為, -603.7%/yr 淨利潤為平均成長. 較弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

VTRS: 2 / 4 年獲利. 較弱. Score = 2 / 4 × 100. ≥ 80 = Pass.

資產負債表 VTRS: D/E比率 1 (適度), 流動比率為 1.3 (充足). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

VTRS: 毛利率為 35.1% (-4.9 pp 趨勢), $16B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 61/100. ≥ 70 = Pass.

分析師展望: 3 / 12 位分析師評級 VTRS 為買入 (25%). 分析師共識目標價為 $15 (+7.8% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

VTRS: 淨利潤率為 -24.6%. 負值. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

市場數據

52週區間6.85-16.47

成交量6.13M

30日平均成交量10.09M

市值$16.02B

Beta（1年）0.82

股息率$0.4800

Share Statistics

EPS（TTM）-3.00

流通股數$1.17B

IPO Date1980-03-17

Employees32,000

CEOScott Andrew Smith

Financial Highlights & Ratios

Revenue (TTM)$14.3B

Gross Profit$5.01B

EBITDA$-395.4M

Net Income$-3.51B

Operating Income$-2.66B

Total Cash$1.45B

Total Debt$14.7B

Net Debt$13.35B

Total Assets$37.19B

Price / Earnings (P/E)-4.6

Price / Sales (P/S)1.12

Analyst Forecast

1Y Price Target$15.50

Target High$18.00

Target Low$12.00

上漲空間+11.4%

評級共識Hold

覆蓋分析師數12

買入 25% 持有 67% 賣出 8%

Price Target Summary

公司資訊

國家US

交易所NASDAQ Global Select

貨幣USD

ISINUS92556V1061

股價走勢

VTRS

Viatris Inc. ↗ · NASDAQ Global Select

Healthcare • Drug Manufacturers - Specialty & Generic

6.85 52WK RANGE 16.47

其他人也在看

TAK

Takeda Pharmaceutical Company Limited

Teva Pharmaceutical Industries Limited

$31.77

+1.99%

ELAN

Elanco Animal Health Incorporated

Dr. Reddy's Laboratories Limited

$13.13

-1.06%

LNTH

Lantheus Holdings, Inc.

$82.74

+1.31%

Viatris Inc. VTRS NASDAQ

VTRS SharesGrow 評分概覽

評分明細 — VTRS

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒